AzTrials
AzTrials

Bowel PreparationMMAI-BPNCT07812155

Multimodal AI-Assisted Bowel Preparation for Colonoscopy

A study testing Multimodal AI-Assisted Bowel Preparation Education in people with Bowel Preparation and Colonoscopy, run by Chiayi Christian Hospital at 1 site in Taiwan.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This randomized controlled trial aims to evaluate the effectiveness of a multimodal artificial intelligence (AI)-assisted smartphone application in improving bowel preparation outcomes among hospitalized adults undergoing colonoscopy. Read more about this study

Who is it for?
Ages 20 years and older
Conditions the study is for
Bowel Preparation, Colonoscopy
What is being tested?
Multimodal AI-Assisted Bowel Preparation Education
Could I receive a placebo?
No, everyone receives an active treatment
How many people
140 participants
Where
1 siteTaiwan
Study dates
10 Mar 2026to 31 Jan 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Hospitalized adults scheduled to undergo colonoscopy.
  • Age 20 years or older.
  • Able to read.
  • Conscious and able to communicate in Mandarin or Taiwanese.
  • Own a smartphone and have basic ability to use the LINE application.

Who cannot join

  • Patients receiving hemodialysis or peritoneal dialysis.
  • Patients unable to take bowel cleansing medication orally.
  • Patients unable to consume a large volume of fluids.
  • Patients with intestinal stenosis, bowel obstruction, or obstructing intestinal tumors.
  • Patients with severe active gastrointestinal bleeding (>1500 mL/day).

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Taiwan1 site, 1 recruiting
  • Chiayi Christian Hospital

    Chiayi City, Taiwan, 60002

    Chieh-Wen Liao, MSN, RN, +886-5-2765041 ext. 3696, 04739@cych.org.tw

    Recruiting

Other trials in Taiwan

About this study

Official title: Exploring the Effectiveness of a Multimodal Artificial Intelligence Application on Bowel Preparation Outcomes for Colonoscopy

This randomized controlled trial aims to evaluate the effectiveness of a multimodal artificial intelligence (AI)-assisted smartphone application in improving bowel preparation outcomes among hospitalized adults undergoing colonoscopy. A total of 140 participants will be randomly assigned in a 1:1 ratio to either an experimental group or a control group. The control group will receive conventional written and verbal nursing education, while the experimental group will receive the same standard education plus a multimodal AI-assisted application delivered through the LINE platform. The application provides structured bowel preparation education, interactive AI-based question-and-answer support, dietary image recognition, stool image analysis, and individualized feedback. Study outcomes will include bowel preparation knowledge, satisfaction with nursing education, and bowel cleansing quality assessed using the Aronchick Scale.

Read the detailed description

Adequate bowel preparation is essential for high-quality colonoscopy because insufficient bowel cleansing may reduce mucosal visualization and affect the detection of colorectal lesions. Conventional bowel preparation education generally relies on written materials and verbal instructions. However, patients may have difficulty understanding dietary restrictions, bowel cleansing medication instructions, and whether bowel cleansing is adequate during the preparation process.

This study evaluates a multimodal AI-assisted smartphone application designed to support patients throughout the bowel preparation process. The application is integrated with the LINE platform and provides structured educational content, including bowel preparation instructions, bowel cleansing medication guidance, dietary preparation, instructional videos, and an interactive AI chatbot for real-time individualized responses.

The application also incorporates two AI-assisted image-recognition functions. First, participants may submit photographs of their meals before colonoscopy. A multimodal AI model analyzes the food images and classifies the dietary pattern as a clear liquid diet, low-residue diet, or regular diet, and provides individualized dietary recommendations. Second, after taking bowel cleansing medication, participants may submit stool images. The system uses a multimodal AI model in combination with a convolutional neural network model to assess bowel cleansing status and provide feedback.

Participants in the control group will receive conventional written and verbal nursing education regarding diet, bowel cleansing medication, and colonoscopy preparation. Participants in the experimental group will receive the same conventional education plus access to the multimodal AI-assisted application. Bowel preparation knowledge will be assessed before and after the intervention, satisfaction with nursing education will be evaluated after colonoscopy, and bowel cleansing quality will be assessed by the endoscopist using the Aronchick Scale.

Being tested
Multimodal AI-Assisted Bowel Preparation Education
Keywords
Artificial Intelligence, Bowel Preparation, Colonoscopy, Smartphone Application, Image Recognition, Patient Education

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Multimodal AI-Assisted Bowel Preparation EducationBehavioural

    Also called AI-Assisted Bowel Preparation Application

    Participants in the experimental group receive conventional bowel preparation education plus a multimodal AI-assisted application delivered through the LINE platform. The application provides structured education on bowel preparation, dietary restrictions, bowel cleansing medication, and examination procedures; interactive AI-based question-and-answer support; dietary image recognition; stool image analysis; and individualized feedback throughout the bowel preparation process. Food images are analyzed to classify dietary patterns as clear liquid, low-residue, or regular diet, while stool images are analyzed using multimodal AI and a convolutional neural network model to assess bowel cleansing status and provide feedback.

Study groups in NCT07812155
Study groupRoleWhat they receive
Multimodal AI-Assisted Education GroupExperimentalParticipants receive conventional written and verbal nursing education plus a multimodal AI-assisted smartphone application delivered through the LINE platform. The application provides structured bowel preparation education, interactive AI-based question-and-answer support, dietary image recognition, stool image analysis, and individualized feedback during the bowel preparation process.
Receives: Behavioral: Multimodal AI-Assisted Bowel Preparation Education
Conventional Nursing Education GroupActive comparatorParticipants receive conventional bowel preparation education provided by nursing staff using written educational materials and verbal instructions regarding dietary restrictions, bowel cleansing medication, and colonoscopy preparation.
Receives: Behavioral: Multimodal AI-Assisted Bowel Preparation Education

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Bowel Cleansing Quality Assessed Using the Aronchick Scale

    Bowel cleansing quality will be assessed by the endoscopist using the Aronchick Scale, which classifies bowel preparation as Excellent, Good, Fair, Poor, or Inadequate. Excellent and Good ratings will be considered adequate bowel preparation.

    Measured: During colonoscopy, approximately 2-3 days after enrollment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Sep 2026
  2. Study start10 Mar 2026
  3. Primary completion31 Jan 2027 (estimated)
  4. Study completion31 Jan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants are randomly assigned in a 1:1 ratio to either an experimental group receiving conventional nursing education plus a multimodal AI-assisted application or a control group receiving conventional nursing education alone. The two groups are studied concurrently without crossover.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
140 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07812155
Sponsor's protocol ID
IRB2026016
Other IDs
IRB2026016
Acronym
MMAI-BP
Status last verified
Sep 2026
First submitted
4 Sep 2026
Last updated
14 Sep 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared because the study protocol and informed consent do not include provisions for public sharing of individual-level participant data. De-identified aggregate study results may be reported in publications and presentations.

Publications

  • Beran A, Aboursheid T, Ali AH, Albunni H, Mohamed MF, Vargas A, Hadaki N, Alsakarneh S, Rex DK, Guardiola JJ. Risk Factors for Inadequate Bowel Preparation in Colonoscopy: A Comprehensive Systematic Review and Meta-Analysis. Am J Gastroenterol. 2024 Dec 1;119(12):2389-2397. doi: 10.14309/ajg.0000000000003073. Epub 2024 Sep 3.

    PubMed 39225554
  • Hassan C, East J, Radaelli F, Spada C, Benamouzig R, Bisschops R, Bretthauer M, Dekker E, Dinis-Ribeiro M, Ferlitsch M, Fuccio L, Awadie H, Gralnek I, Jover R, Kaminski MF, Pellise M, Triantafyllou K, Vanella G, Mangas-Sanjuan C, Frazzoni L, Van Hooft JE, Dumonceau JM. Bowel preparation for colonoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2019. Endoscopy. 2019 Aug;51(8):775-794. doi: 10.1055/a-0959-0505. Epub 2019 Jul 11.

    PubMed 31295746
  • Gimeno-Garcia AZ, Benitez-Zafra F, Nicolas-Perez D, Hernandez-Guerra M. Colon Bowel Preparation in the Era of Artificial Intelligence: Is There Potential for Enhancing Colon Bowel Cleansing? Medicina (Kaunas). 2023 Oct 15;59(10):1834. doi: 10.3390/medicina59101834.

    PubMed 37893552
  • Desai M, Nutalapati V, Bansal A, Buckles D, Bonino J, Olyaee M, Rastogi A. Use of smartphone applications to improve quality of bowel preparation for colonoscopy: a systematic review and meta-analysis. Endosc Int Open. 2019 Feb;7(2):E216-E224. doi: 10.1055/a-0796-6423. Epub 2019 Jan 18.

    PubMed 30705956
  • Chen HY, Tu MH, Chen MY. Effectiveness of a Mobile Health Application for Educating Outpatients about Bowel Preparation. Healthcare (Basel). 2024 Jul 10;12(14):1374. doi: 10.3390/healthcare12141374.

    PubMed 39057517

Questions about this trial

What is this clinical trial studying?

A study testing Multimodal AI-Assisted Bowel Preparation Education in people with Bowel Preparation and Colonoscopy, run by Chiayi Christian Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 14 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Bowel Cleansing Quality Assessed Using the Aronchick Scale (time frame: During colonoscopy, approximately 2-3 days after enrollment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07812155, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Sep 2026; AzTrials last refreshed its copy on 30 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in